Allylescaline (4-allyloxy-3,5-dimethoxyphenethylamine) is a lesser-known psychedelic drug. It is closely related in structure to mescaline. Allylescaline was first synthesized by Otakar Leminger in 1972.[1] The compound was later synthesized by Alexander Shulgin and further described in his book PiHKAL.[2] The dosage range is listed as 20–35 mg, and the duration 8–12 hours.[2] Allylescaline produces an entactogenic warmth, an entheogenic effect, and a feeling of flowing energy. Very little data exists about the pharmacological properties, metabolism, and toxicity of allylescaline.

Sweden

Allylescaline is illegal in Sweden as of January 2016.[3]

United States

Allylescaline is not directly scheduled under the Controlled Substances Act. However, due to its structural similarities with mescaline, it could potentially be prosecuted under the Federal Analogue Act if sold for human consumption.

See also

References

  1. ^ Leminger, Otakar (1972). "The Chemistry of Alkoxylated Phenethylamines – Part 2". Chemický Průmysl. 22: 553.
  2. ^ a b AL Entry in PiHKAL
  3. ^ "31 nya ämnen kan klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. November 2015.


Allikas: https://en.wikipedia.org/wiki/Allylescaline
No tags for this post.